ABSTRACT
BACKGROUND: Currently, the treatment outcomes for complex congenital arteriovenous malformations (AVMs) remain unsatisfactory. This article reports on the utilization of an abdominal aortic stent graft, in conjunction with embolization techniques, for managing acute heart failure triggered by complex congenital arteriovenous malformations in the lower limb. CASE PRESENTATION: We present a case involving a patient with congenital AVMs in the lower limb, who had suffered from prolonged swelling in the left lower limb and recently developed symptoms of heart failure. At the age of 67, the patient was definitively diagnosed with a complex congenital AVMs in the lower limb. This article delves into the practical experiences and limitations encountered in employing an abdominal aortic stent graft, coupled with embolization, to address acute heart failure caused by complex congenital AVMs in the lower limb. CONCLUSIONS: Our article presents the initial report on the challenges and limitations encountered in treating acute heart failure triggered by complex congenital AVMs in the lower limb, utilizing a combination of abdominal aortic stent graft placement and embolization techniques.
Subject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Endovascular Procedures , Heart Failure , Lower Extremity , Stents , Humans , Embolization, Therapeutic/instrumentation , Treatment Outcome , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Lower Extremity/blood supply , Endovascular Procedures/instrumentation , Heart Failure/therapy , Heart Failure/diagnosis , Heart Failure/physiopathology , Heart Failure/etiology , Aged , Blood Vessel Prosthesis Implantation/instrumentation , Male , Blood Vessel Prosthesis , FemaleABSTRACT
Intraosseous occurrence of a spinal AVM is anecdotal, with only four such cases reported previously. This is the first report of a spinal intraosseous AVM in the cervical vertebrae. A 44-year-old male patient presented with a 2-month history of progressive quadriparesis and bladder dysfunction. Magnetic resonance imaging showed multiple flow voids within the C4 and C5 vertebral bodies, and an extradural component causing cord compression. CT showed extensive bony destruction at both levels. The diagnosis of an intraosseous AVM was confirmed with spinal angiography. The AVM was noted to be fed by branches from the ascending cervical arteries and the vertebral artery. The nidus was draining into the vertebral venous plexus and thence into the jugular vein through the marginal sinus. The patient underwent partial embolization of the AVM. Surgical resection was attempted but found to be unfeasible due to torrential bleeding. A 360-degree stabilization along with decompressive laminectomies was performed, resulting in clinical improvement and disease stabilization at one year follow-up. The case and its management dilemmas are discussed in light of a brief literature review.
Subject(s)
Arteriovenous Malformations , Cervical Vertebrae , Embolization, Therapeutic , Humans , Male , Adult , Cervical Vertebrae/surgery , Cervical Vertebrae/diagnostic imaging , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/surgery , Arteriovenous Malformations/therapy , Embolization, Therapeutic/methods , Vertebral Artery/diagnostic imaging , Vertebral Artery/surgery , Vertebral Artery/abnormalities , Spinal Cord Compression/surgery , Spinal Cord Compression/etiology , Spinal Cord Compression/diagnostic imaging , Treatment Outcome , Magnetic Resonance Imaging , Laminectomy/methods , Decompression, Surgical/methodsABSTRACT
A boy in his mid-teens presented with progressively increasing bleeding from the right eye and nostril intermittently over a period of 6 weeks. A complete ophthalmic examination revealed nothing significant. His otorhinological examination and haematological investigations were within normal limits. The patient came a month later with frank bleeding from the right eye. Ophthalmic examination revealed hyperaemia and maceration of the right lower palpebral conjunctiva. A histopathological examination of conjunctival scrapings from the site showed abnormal dilated blood vessels suggestive of a vascular malformation. Digital subtraction angiography confirmed the presence of a conjunctival micro arteriovenous malformation supplied by the external carotid and ophthalmic artery branches. He underwent successful transarterial Onyx embolisation resulting in complete resolution of the haemolacria.
Subject(s)
Conjunctiva , Embolization, Therapeutic , Humans , Male , Embolization, Therapeutic/methods , Conjunctiva/blood supply , Eye Hemorrhage/therapy , Eye Hemorrhage/etiology , Angiography, Digital Subtraction , Arteriovenous Malformations/therapy , Arteriovenous Malformations/complications , Arteriovenous Malformations/diagnostic imaging , Adolescent , Ophthalmic Artery/diagnostic imaging , Ophthalmic Artery/abnormalities , Vascular Malformations/therapy , Vascular Malformations/complications , Vascular Malformations/diagnosis , Polyvinyls/therapeutic use , Conjunctival Diseases/therapy , Treatment Outcome , Hemobilia/therapy , Hemobilia/etiologyABSTRACT
OBJECTIVE: Aim: To analyze the embolic migration complication during arteriovenous malformations (AVMs) embolization of the head and neck localization, and to demonstrate the possibility of tromboaspiration method in treatment of such complications in cerebrovascular region. PATIENTS AND METHODS: Materials and Methods: The endovascular intervention was performed in 116 patients with AVMs of the head and neck localization. We used a superselective catheterization of the external cerebral artery branches as a treatment method of AVMs embolization. During embolization of AVMs, the spherical and not spherical polyvinyl alcohol (PVA) emboli were implanted. RESULTS: Results: The result of treatment was technically successful in 112 (96,6 %) patients with AVMs of the head and neck localization. There were 4 (3,5 %) cerebrovascular complications during AVMs embolization of the head and neck localization. In 2 cases a cerebrovascular complication arose during the AVMs embolization of head localizations. In those 2 cases the cerebrovascular complications were successfully treated conservatively. In other 2 cases cerebrovascular complications arose during the AVMs embolization of neck localizations. One patient died as result of a massive ischemic stroke in the vertebrobasilar zone. Another patient was successful treated by tromboaspiration method. CONCLUSION: Conclusions: Any surgical intervention on the carotid arteries, including endovascular surgery, is associated with a risk to the health and life of the patient. A thorough angiographic diagnosis of the external and internal carotid and vertebral arteries is necessary before endovascular embolization. Modern endovascular technology, such as tromboaspiration, may be helpful to avoid embolic migration complication in cerebrovascular region.
Subject(s)
Embolization, Therapeutic , Humans , Embolization, Therapeutic/methods , Embolization, Therapeutic/adverse effects , Female , Male , Adult , Middle Aged , Arteriovenous Malformations/therapy , Head/blood supply , Young Adult , Neck/blood supply , Treatment Outcome , AdolescentABSTRACT
PURPOSE: To evaluate the angiographic recanalization rate of patients who underwent embolization juxta-proximal to the sac with AMPLATZER Vascular Plug type IV (AVP IV) for a simple pulmonary arteriovenous malformation (PAVM). MATERIAL AND METHODS: Ten patients (7 females and 3 males; median age, 47 years [range 28-83 years]) with 19 simple-type PAVMs who underwent embolization using an AVP IV between May 2015 and November 2021 were included in this retrospective study. The median feeding artery diameter on computed tomography was 4.0 mm (range 3-5.9 mm), and the median ratio of AVP IV size to feeding artery diameter on computed tomography was 1.5 (range 1.3-2.1). Technical success was defined by AVP IV placement at the junction between the pulmonary artery and the sac, or the pulmonary artery within 1 cm from the junction and beyond the last normal branch. The primary endpoint was the PAVM recanalization rate in selective or segmental pulmonary angiography performed 1 year post-embolization. RESULTS: The technical success rate of embolization juxta-proximal to the sac for simple-type PAVMs was 100%. None of the 19 lesions showed recanalization in pulmonary angiography performed 1 year after embolization. One patient experienced hemoptysis and pneumonia. CONCLUSION: Embolization of simple-type PAVMs' feeding vessel using AVP IV is safe and effective, with a high technical success rate and no recanalization on pulmonary angiography performed at 1 year post-embolization.
Subject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Pulmonary Artery , Pulmonary Veins , Humans , Female , Male , Middle Aged , Adult , Aged , Pulmonary Artery/abnormalities , Pulmonary Artery/diagnostic imaging , Retrospective Studies , Embolization, Therapeutic/methods , Aged, 80 and over , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Treatment Outcome , Angiography , Tomography, X-Ray Computed/methods , Septal Occluder Device , Computed Tomography Angiography/methodsABSTRACT
BACKGROUND: Clinically, arteriovenous malformations in the buttocks (bAVMs) are extremely rare. Our study aimed to evaluate the efficacy and safety of ethanol embolotherapy in managing bAVMs. RESULTS: A total of 32 patients with bAVMs (14 females and 18 males) from 2012 to 2021 were included in this study. All patients underwent complete clinical and imaging examinations. Further, the AVMs lesions were analyzed according to Schöbinger staging and Yakes classification. Each patient had undergone a multistage ethanol embolization. The amelioration of clinical symptoms and devascularization on angiography were evaluated at regular follow-ups. In the present cohort, the 11-20 age group had the most patients (15/32; 46.88%). A total of 124 embolization procedures were performed (average 3.88 procedures per patient), and the average dose of absolute ethanol was 18.96 mL per procedure. Thirteen patients with dominant draining veins underwent additional coil deployment before ethanol embolization (13/32; 40.63%). During follow-ups, clinical improvement was found in 23 of 27 who presented with a pulsating mass (85.19%), 17 of 20 with abnormal local skin temperature (85%), 5 of 6 with bleeding (83.33%), and 5 of 5 patients treated for pain (100%). More than 75% angiographic devascularization was achieved in 18 patients (18/32; 56.25%). Finally, 12 out of 13 patients (92.31%) reduced from Schöbinger Stage III to a lower grade, and ten patients exhibited a complete response (10/32; 31.23%). There was a single serious complication of local necrosis, while neither paranesthesia nor infection was observed postoperatively. CONCLUSIONS: Ethanol embolization assisted with coils can treat bAVMs effectively and safely. The Yakes classification contributed to the optimal ethanol embolotherapy of bAVMs.
Subject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Ethanol , Humans , Embolization, Therapeutic/methods , Female , Male , Ethanol/therapeutic use , Arteriovenous Malformations/therapy , Buttocks/blood supply , Adult , Young Adult , Adolescent , Child , Middle Aged , Treatment OutcomeSubject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Enbucrilate , Pulmonary Artery , Pulmonary Veins , Humans , Enbucrilate/therapeutic use , Embolization, Therapeutic/methods , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/abnormalities , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Endovascular Procedures/methods , Treatment OutcomeABSTRACT
PURPOSE: To evaluate the correlation between pulmonary hypertension (PH) and recurrence of pulmonary arteriovenous malformation (PAVM) after embolization. MATERIALS AND METHODS: With institutional review board (IRB) approval, the records of 377 patients with PAVMs evaluated at a single hereditary hemorrhagic telangiectasia (HHT) center of excellence between January 1, 2013, and September 10, 2023, were retrospectively reviewed. PAVMs embolized during this time period were evaluated for recurrence. Patients and PAVMs not treated during this time period were excluded. Growth of previously untreated PAVMs was not considered recurrence. Patients without chest computed tomography (CT) follow-up were excluded. General demographics, HHT status as defined by genetic testing or Curacao criteria, presence of PH, history of smoking, anemia, and hepatic arteriovenous malformations (AVMs) were documented. Odds ratio (OR) was calculated and stratified analysis was performed to assay the correlation between PAVM recurrence, PH, and possible confounders. RESULTS: A total of 151 patients with PAVMs were treated during the study period, including 438 PAVMs, for which follow-up was available. This included 106 patients with definite, 31 with doubtful, and 14 with possible HHT. The presence of PH was significantly associated with PAVM recurrence both by patient (OR, 8.13; 95% CI, 3.50-19.67) and by lesion (OR, 4.07; 95% CI, 2.14-7.91). Multivariate analysis demonstrated that this correlation was independent of several variables including HHT status, smoking history, presence of hepatic AVMs, and anemia. CONCLUSIONS: There is a high correlation between PH and PAVM recurrence, suspected to be due to high pulmonary artery pressures causing recanalization. PH may suggest the need for shorter surveillance intervals.
Subject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Hypertension, Pulmonary , Pulmonary Artery , Pulmonary Veins , Recurrence , Humans , Female , Male , Pulmonary Artery/abnormalities , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/physiopathology , Retrospective Studies , Embolization, Therapeutic/adverse effects , Middle Aged , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/diagnostic imaging , Hypertension, Pulmonary/physiopathology , Hypertension, Pulmonary/therapy , Treatment Outcome , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Pulmonary Veins/physiopathology , Adult , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/complications , Risk Factors , Time Factors , Aged , Telangiectasia, Hereditary Hemorrhagic/complications , Telangiectasia, Hereditary Hemorrhagic/diagnostic imaging , Telangiectasia, Hereditary Hemorrhagic/therapy , Young Adult , Arterial PressureABSTRACT
BACKGROUND: Mandibular arteriovenous malformation (AVM) is rare. Our work aims to introduce the ethanol embolization of a patient suffering from acute oral hemorrhage induced by mandibular AVM. METHODS: A 35-year-old woman without coagulopathy underwent tooth extraction, and the acute oral bleeding occurred intraoperatively. Imaging examinations indicated the enhancement of vascular mass with bone destruction inside the mandible. Angiography finally confirmed the high blood flow nature and the diagnosis of AVM. RESULTS: During the interventional procedure, the coils were first applied into the dilated outflowing vein to slow down the blood flow rate of mandibular AVM. Absolute ethanol was injected in a multi-bolus modality to destroy the nidus of AVM. Her mandibular lesion had been stable in the 12-month re-examined angiography, no further bleeding occurred during the period. CONCLUSIONS: Ethanol embolotherapy was a less invasive, more precise, and quick-action approach managing AVM of the jaw and related emergency medicine.
Subject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Ethanol , Mandible , Oral Hemorrhage , Tooth Extraction , Humans , Female , Embolization, Therapeutic/methods , Adult , Arteriovenous Malformations/therapy , Arteriovenous Malformations/complications , Ethanol/administration & dosage , Tooth Extraction/adverse effects , Oral Hemorrhage/etiology , Oral Hemorrhage/therapy , Mandible/blood supply , AngiographyABSTRACT
PURPOSE: To investigate the safety and efficacy of microballoon-occluded transcatheter embolization using n-butyl-2-cyanoacrylate (NBCA) in patients with a single pulmonary arteriovenous malformation (PAVM). METHODS: From November 2017 to November 2020, this retrospective study included 38 previously untreated patients with a single PAVM who underwent microballoon-occluded transcatheter embolization using NBCA. All 38 patients had follow-up that included simple chest radiography and contrast-enhanced chest computed tomography (CT). RESULTS: A microballoon was successfully placed in a feeding artery of the PAVM to control the delivery of the NBCA cast in all 38 patients, with complete embolization of sacs and the feeding artery achieved in all cases. The mean diameters of the feeding artery, sac, and draining vein were 3.9 ± 0.9 mm, 7.5 ± 2.6 mm, and 4.6 ± 1.3 mm, respectively. A fixed 1:2 NBCA/Lipiodol ratio was used, and the mean amount of embolic mixture per patient was 1.4 mL (range 0.6-2.2 mL). There were no complications related to microballoon adhesion and non-target embolization of the systemic circulation. Follow-up CT in all 38 patients with a mean delay of 34.5 ± 8.8 months (range 20.7-56.5 months) showed no continued perfusion of the PAVM. CONCLUSION: In our hands, microballoon-occluded n-butyl-2-cyanoacrylate embolization seemed to be safe and appeared to be clinically effective in patients with simple and complex types of single PAVM. Therefore, the present technique has the potential to become a standard treatment for a single PAVM.
Subject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Enbucrilate , Pulmonary Artery , Pulmonary Veins , Humans , Male , Female , Enbucrilate/therapeutic use , Enbucrilate/administration & dosage , Retrospective Studies , Embolization, Therapeutic/methods , Adult , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/abnormalities , Middle Aged , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Treatment Outcome , Young Adult , Adolescent , Aged , Tomography, X-Ray ComputedABSTRACT
BACKGROUND AND PURPOSE: The prognosis of untreated spinal arteriovenous malformations (SAVMs) is poor. Embolization plays an important role in the management of intramedullary SAVMs. Delayed aggravation due to spinal venous thrombosis following successful embolization has been reported; however, perioperative management strategies to prevent thrombosis have not been explored. We present our single-center experience of SAVM embolization and perioperative management, including anticoagulation. MATERIAL AND METHODS: We retrospectively evaluated 18 patients with SAVMs who underwent transarterial embolization. Perioperative anticoagulation therapy was administered to selected patients. We compared the characteristics of the patients, including perioperative management procedures, between those with and without postoperative worsening following embolization. RESULTS: Acute postoperative worsening within 1 week occurred in 4 (22.2%) patients. Of these, immediate worsening was observed in one patient as a procedure-related complication. Delayed worsening after 24â¯h was observed in 3 patients, caused by delayed venous thrombosis with severe back pain. Rescue anticoagulation for delayed worsening improved symptoms in two patients. A comparison between patients with and without acute postoperative worsening revealed significant differences in age (median 46.5 vs. 26.5 years, pâ¯= 0.009) and the presence of postoperative back pain (75.0% vs. 0%, pâ¯= 0.005); however, there was no significant difference in use of selective anticoagulation (pâ¯= 0.274). CONCLUSION: The results of this study suggest that SAVM embolization can cause acute worsening due to postoperative venous thrombosis with severe back pain, which may be reversed by anticoagulation therapy. Back pain is an important finding that suggests venous thrombosis, and anticoagulation should be urgently administered.
Subject(s)
Anticoagulants , Embolization, Therapeutic , Venous Thrombosis , Humans , Embolization, Therapeutic/methods , Female , Male , Adult , Middle Aged , Retrospective Studies , Venous Thrombosis/diagnostic imaging , Venous Thrombosis/etiology , Anticoagulants/therapeutic use , Treatment Outcome , Back Pain/etiology , Perioperative Care/methods , Young Adult , Spinal Cord/blood supply , Spinal Cord/diagnostic imaging , Adolescent , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/complications , Postoperative Complications/etiology , Postoperative Complications/prevention & controlABSTRACT
Arteriovenous malformations of the head and neck are rare and inborn errors of vascular morphogenesis. They pose therapeutic challenges owing to their bleeding tendency and a high chance of recurrence. Treatment modalities include digital subtraction angiography with embolisation as a primary treatment or can be done preoperatively followed by surgical excision. We present a case of recurrent arteriovenous malformation of the postauricular region in an adolescent male who was taken up for upfront surgical excision with the help of a tumescent solution, thereby eliminating the need for embolisation and drastically reduced intraoperative blood loss.
Subject(s)
Arteriovenous Malformations , Humans , Male , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/therapy , Arteriovenous Malformations/surgery , Adolescent , Recurrence , Angiography, Digital Subtraction , Blood Loss, Surgical/prevention & control , Embolization, Therapeutic/methods , Treatment OutcomeABSTRACT
PURPOSE: To assess the different adjunctive catheter techniques required to achieve complete occlusion of renal arteriovenous malformations (rAVMs) of different angioarchitectural types. MATERIALS AND METHODS: Overall, data on 18 patients with rAVM (Type 1, n = 7; Type 2, n = 2; Type 3, n = 9; mean age, 53.8 years) who underwent 25 procedures between 2011 and 2022 were reviewed. The clinical presentations, endovascular techniques, arteriovenous malformation (AVM) occlusion rate, adverse events (including the incidence of renal infarction), and clinical symptoms and outcomes (including recurrence/increase of AVM) were analyzed according to the Cho-Do angioarchitectural classification. Posttreatment renal infarction was classified as no infarction, small infarction (<12.5%), medium infarction (12.5%-25%), and large infarction (>25%) using contrast-enhanced computed tomography or magnetic resonance imaging. RESULTS: Hematuria and heart failure were presenting symptoms in 10 and 2 patients, respectively. The embolic materials used were as follows: Type 1 rAVM, coils alone or with n-butyl-2-cyanoacrylate (nBCA); Type 2 rAVM, nBCA alone or with coils; and Type 3 rAVMs, nBCA alone. Fourteen patients underwent adjunctive catheter techniques, including flow control with a balloon catheter and multiple microcatheter placement, alone or in combination. Immediate postprocedural angiography revealed complete occlusion in 15 patients (83%) and marked regression of rAVM in 3 (17%). Small asymptomatic renal infarctions were observed in 6 patients with Type 3 rAVMs without any decrease in renal function. No major adverse events were observed. All symptomatic patients experienced symptom resolution. Recurrence/increase of rAVM was not observed during the mean 32-month follow-up period (range, 2-120 months). CONCLUSIONS: Transarterial embolization using adjunctive catheter techniques according to angioarchitectural types can be an effective treatment for rAVMs.
Subject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Renal Artery , Renal Veins , Humans , Middle Aged , Female , Male , Embolization, Therapeutic/adverse effects , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Treatment Outcome , Adult , Retrospective Studies , Aged , Renal Artery/diagnostic imaging , Renal Artery/abnormalities , Renal Veins/diagnostic imaging , Renal Veins/abnormalities , Computed Tomography Angiography , Predictive Value of Tests , Recurrence , Time Factors , Young Adult , Risk Factors , Enbucrilate/administration & dosage , Infarction/diagnostic imaging , Infarction/etiology , Infarction/therapy , Magnetic Resonance AngiographySubject(s)
Arteriovenous Malformations , Embolization, Therapeutic , Pulmonary Artery , Pulmonary Veins , Recurrence , Female , Humans , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/therapy , Arteriovenous Malformations/surgery , Embolization, Therapeutic/instrumentation , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/abnormalities , Pulmonary Artery/surgery , Pulmonary Veins/abnormalities , Pulmonary Veins/diagnostic imaging , Pulmonary Veins/surgery , Treatment Outcome , Middle AgedABSTRACT
PURPOSE: To evaluate the safety, technical success and short-term effectiveness of polyurethane-covered stent (PK Papyrus, BioTronik, Berlin) in the treatment of pulmonary arteriovenous malformations (PAVMs) that are not amenable to embolotherapy. MATERIALS AND METHODS: In this IRB-approved, retrospective study, data from patients who received polyurethane-covered stents for exclusion of PAVMs were analyzed. The study included 5 patients (all women) with a median age of 40 years (range 25-60). Patients presented with hypoxemia, TIAs, and/or epistaxis; 4 were confirmed to have HHT. All had multiple PAVMs diagnosed on chest CT and underwent embolization with other devices in addition to the polyurethane-covered stent. The indication for stent placement in all cases was a short and/or tortuous feeding artery. Safety was assessed by immediate or short-term complications, e.g., migration, stent thrombosis, and fracture. Technical success was defined as the ability to accurately place the stent at the intended location. Effectiveness was defined as successful exclusion of PAVM with no perfusion across the AVM. RESULTS: Technical success of stent placement was 100%. AVM exclusion rate was 80% after single stent deployment; in the case of incomplete exclusion, success was achieved using an overlapping stent to completely cover a second feeding artery. During the median follow-up period of 5 months (range 2-10), all stents remained patent, and AVMs were excluded without other complications. CONCLUSION: Exclusion of PAVMs with polyurethane-covered stents is technically feasible, safe, and shows short-term effectiveness for PAVMs with a short/tortuous feeding artery when traditional embolization techniques are not possible.
Subject(s)
Arteriovenous Fistula , Arteriovenous Malformations , Embolization, Therapeutic , Pulmonary Artery/abnormalities , Pulmonary Veins , Pulmonary Veins/abnormalities , Telangiectasia, Hereditary Hemorrhagic , Humans , Female , Adult , Middle Aged , Polyurethanes , Telangiectasia, Hereditary Hemorrhagic/therapy , Retrospective Studies , Treatment Outcome , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/therapy , Arteriovenous Malformations/complications , Pulmonary Veins/diagnostic imaging , Pulmonary Artery/diagnostic imaging , Stents/adverse effects , Embolization, Therapeutic/methodsABSTRACT
A woman in her 20s, who was pregnant, underwent a routine antenatal ultrasound revealing organised intraventricular haemorrhage and a vascular area in the left thalamic region. Fetal MRI raised suspicion of arteriovenous malformation (AVM). The baby was delivered at 36 weeks via C-section, and initial brain MRI suggested a possible neoplastic lesion.Cerebral angiography confirmed a large AVM involving the left choroid plexus with arterial feeders from the left anterior and posterior choroidal arteries and a large venous varix draining into the vein of Galen. Both arterial feeders were successfully embolised with Onyx and glue, achieving complete occlusion.Choroid plexus AVMs are rare and often lead to intraventricular or intraparenchymal haemorrhage. Surgical treatment has shown success, but endovascular management is effective, especially for small, deep-seated AVMs, offering a better prognosis.
Subject(s)
Arteriovenous Malformations , Choroid Plexus , Female , Pregnancy , Infant , Humans , Choroid Plexus/diagnostic imaging , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/therapy , Fetus , Prenatal Care , Cerebral Hemorrhage/diagnostic imaging , Cerebral Hemorrhage/etiologyABSTRACT
PURPOSE: Analysis of clinical and diagnostic findings in rare urogenital and perineal vascular malformations only occurring in 2-3â% of vascular anomalies with regard to clinical symptoms and treatment decisions. MATERIALS AND METHODS: All 25 out of 537 patients presenting with congenital urogenital and perineal vascular malformations at our institution from 2014 to 2021 were included. Vascular anomaly classification, anatomical location, clinical symptoms at presentation, diagnostic imaging, and pain intensity were retrospectively assessed from the patient record and therapy management was evaluated. RESULTS: In total, 25 patients (10 females (40â%), 15 males (60â%)), aged 6 to 77 years were included. Diagnoses were: 10 (40â%) venous malformations (VMs), 5 (20â%) lymphatic malformations (LMs) and 10 (40â%) arteriovenous malformations (AVMs). Malformation manifestations were: 12 (32â%) lesser pelvis, 12 (32â%) external genitalia, and 13 (34â%) perineal/gluteal region. One AVM was located in the kidney. The leading clinical symptom was pain. The mean intensity was 6.0/10 for LM, 5.7/10 for VM, and 4.5/10 for AVM. Further major symptoms included physical impairment, local swelling, and skin discoloration. Bleeding complications or sexual dysfunction were rare findings. Patients with VM reported significantly more symptoms than patients with AVM (pâ=â0.0129). In 13 patients (52â%) minimally invasive therapy was indicated: 10 (77â%) sclerotherapies and 3 (23â%) transcatheter embolization procedures. Complete symptomatic remission was achieved in 9 (69â%) patients, partial response in 3 (23â%) patients, and 1 patient showed no clinical response to therapy. Follow-up appointments without the need for immediate minimally invasive therapy were significantly more common in patients with AVMs than in patients with VMs (pâ=â0.0198). CONCLUSION: To create a higher awareness of congenital urogenital and perineal vascular malformations. Awareness of this rare condition avoids misdiagnosis. Therapy decisions should be symptom-oriented. Emergency intervention is rarely required, even in fast-flow vascular malformations. KEY POINTS: · Venous malformations cause more symptoms with higher pain intensity than arteriovenous malformations.. · Diagnosis and adequate treatment can be hampered by a lack of awareness of the clinical presentation.. · Bleeding complications are rare, even in high-flow vascular malformations.. · Pain and physical impairment are the most commonly observed symptoms in these patients..
Subject(s)
Arteriovenous Malformations , Vascular Malformations , Male , Female , Humans , Retrospective Studies , Vascular Malformations/diagnostic imaging , Vascular Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Arteriovenous Malformations/therapy , Diagnostic Imaging , Pain , Treatment OutcomeABSTRACT
PURPOSE: To compare the safety, effectiveness, and persistence rates of 0.018-inch coils with those of Amplatzer vascular plugs (AVPs; Abbott Vascular, Abbott Park, Illinois) for the treatment of pulmonary arteriovenous malformations (PAVMs) in response to a growing concern that 0.018-inch coil embolization would increase the long-term persistence rate. MATERIALS AND METHODS: This is a retrospective, single-center study of a database (2002-2020) of 633 PAVM embolizations. Complex PAVMs and those not embolized with 0.018-inch coils or plugs were excluded. PAVM embolization material was classified into 4 groups: (a) 0.018-inch nonfibered coils (NFCs), (b) 0.018-inch fibered coils (FCs), (c) NFCs and FCs, or (d) plugs. Persistence was defined as flow through the PAVM on digital subtraction angiography (DSA) or as <30% diameter reduction of the aneurysmal sac on unenhanced computed tomography (CT). Kaplan-Meier analysis and Cox regression were used to assess PAVM's persistence-free survival. RESULTS: A total of 312 PAVM embolizations with NFCs (43 PAVMs), FCs (127 PAVMs), NFCs and FCs (12 PAVMs), or plugs (130 PAVMs) in 109 patients (28% men; mean age = 49 years) were included. All PAVM embolizations were technically successful without any major adverse events. PAVM persistence-free survival rates at 10 years' follow-up were 40.8% versus 44.7% in the NFC and FC groups (P = .22) and 47.3% versus 81.0% in the 0.018-inch coil (NFC or FC) and plug groups (P < .0001), respectively. There were 0.43 (79/182) and 0.08 (10/130) re-embolization procedures per PAVM in the 0.018-inch coil and plug groups, respectively (P < .001). CONCLUSIONS: PAVM embolization with 0.018-inch coils was safe, but persistence rate with PAVM embolization was significantly higher than that with plugs, with no significant differences between FCs and NFCs.